DB
AUPH icon

Danske Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

Danske Bank’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.45K Sell
300
-3,300
-92% -$48.2K ﹤0.01% 925
2025
Q4 		$57.4K Sell
3,600
-72,820
-95% -$1.03M ﹤0.01% 946
2025
Q3 		$844K Sell
76,420
-21,823
-22% -$238K ﹤0.01% 712
2025
Q2 		$832K Buy
+98,243
New +$788K ﹤0.01% 733

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Danske Bank's AUPH Position: Q1 2026 in Review

Danske Bank reduced its Aurinia Pharmaceuticals (AUPH) stake by 92% in Q1 2026, selling an estimated $48.2K and leaving 300 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Danske Bank first reported a position in AUPH in Q2 2025 and has held it in 4 quarters since. The position peaked at $844K in Q3 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Danske Bank held 300 shares of Aurinia Pharmaceuticals worth $4.45K as of Q1 2026.
  • Danske Bank sold 3,300 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $48.2K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #925 holding.
  • Danske Bank first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Danske Bank's Aurinia Pharmaceuticals position peaked at $844K in Q3 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.